Анемия беременных в XXI веке. Позиция гематолога


DOI: https://dx.doi.org/10.18565/pharmateca.2020.6.92-99

Н.И. Стуклов (1, 2), Т.В. Сушинская (2), А.А. Митченкова (1), М.С. Ковальчук (1)

1) Российский университет дружбы народов (РУДН), Москва, Россия; 2) Московский научно-исследовательский онкологический институт им. П.А. Герцена, филиал НМИЦ радиологии, Москва, Россия
В статье рассматривается современное состояние проблемы анемии беременных. Подробно обсуждаются критерии анемии, эпидемиология и значение этого состояния для матери и плода. Описываются существующие представления о состоянии кроветворения и обмена железа при беременности, рассматривается дефицит железа в качестве основной причины анемии, приводятся современные подходы и алгоритмы его диагностики. Обсуждаются вопросы профилактики и лечения анемии с учетом последних отечественных и зарубежных рекомендаций. В вопросах лечения анемии представлены разные взгляды и суждения об оптимальном лечении анемии, рассматриваются достоинства и недостатки пероральной и парентеральной терапии препаратами железа, дифференцированного подхода в зависимости от тяжести и патогенетического варианта анемии. Содержащиеся в статье данные представляют собой комплексный современных взгляд гематолога на проблему анемии беременных в XXI в.
Ключевые слова: анемия беременных, дефицит железа, профилактика анемии, лечение анемии, патогенез анемии беременных, осложнения анемии

Литература


1. WHO: Iron deficiency anaemia: assessment, prevention and control. WHO/NHD/01.3. Geneva: WHO; 2001.


2. Centers for Disease Control and Prevention. Recommendations to prevent and control iron deficiency in the United States. MMWR. 1998;47(RR-3):1–29.


3. American College of Obstetrics & Gynecology. ACOG Practice Bulletin No. 95: Anemia in pregnancy. Obstet Gynecol. 2008;112:201–7. Doi: 10.1097/AOG.0b013e3181809c0d.


4. Pavord S., Daru J., Prasannan N., et al. UK guidelines on the management of iron deficiency in pregnancy. Br J Haematol. 2020;188(6):819–30. Doi: 10.1111/bjh.16221.


5. Pavord S., Myers B., Robinson S., et al. UK guidelines on the management of iron deficiency in pregnancy. Br J Haematol. 2012;156:588–600. Doi: 10.1111/j.1365-2141.2011.09012.x.


6. de Leeuw N.K., Lowenstein L., Hsieh Y.S. Iron deficiency and hydremia in normal pregnancy. Medicine. 1966;45:291–315. Doi: 10.1097/00005792-196607000-00002.


7. Демихов В.Г., Морщакова Е.Ф., Румянцев А.Г. Патогенез и лечение анемии беременных. М.: Практическая медицина, 2015. 224 с. [Demikhov V.G., Morshchakova E.F., Rumyantsev A.G.


Pathogenesis and treatment of anemia in pregnant women. M.: Prakticheskaya meditsina, 2015. 224 p. (In Russ.)].


8. Milman N., Byg K.E., Agger A.O. Hemoglobin and erythrocyte indices during normal pregnancy and postpartum in 206 women with and without iron supplementation. Acta Obstet Gynecol Scand. 2000;79:89–98. Doi: 10.1034/j.1600-0412.2000.079002089.x.


9. Stevens G.A., Finucane M.M., De-Regil L.M., et al. Nutrition Impact Model Study Group (Anaemia). Global, regional, and national trends in haemoglobin concentration and prevalence of total and severe anaemia in children and pregnant and non-pregnant women for 1995–2011: a systematic analysis of population-representative data. Lancet Glob Health. 2013 Jul; 1(1):e16–25.


10. Cantor A.G., Bougatsos C., Dana T., et al. Routine iron supplementation and screening for iron deficiency anemia in pregnancy: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2015;162(8):566–76. Doi: 10.7326/M14-2932.


11. The global prevalence of anaemia in 2011. Geneva: World Health Organization; 2015.


12. DeMaeyer E., Adiels-Tegman M. The prevalence of anaemia in the world. World Health Statistics Quarterly. 1985;38:302–16.


13. World Health Organization. The Prevalence of Anaemia in Women: A Tabulation of Available Information. 1992 (WHO/MCH/MSM/92.2).


14. Worldwide prevalence of anaemia 1993–2005: WHO global database on anaemia. Geneva, World Health Organization, 2008.


15. Логутова Л.С. Анемия у беременных: вопросы этиологии, диагностики и лечения. РМЖ. Мать и дитя. 2016;5:290–93.


16. Scholl T.O. Iron status during pregnancy: setting the stage for mother and infant. Am J Clin Nutr. 2005;81:1218S–22S. Doi: 10.1093/ajcn/81.5.1218.


17. World Health Organization. Nutrition: Micronutrient deficiencies. https:// www.who.int/nutrition/topics/micronutrients/en/ (2017). Accessed 15 June 2017.


18. deMaeyer Е.М. with the collaboration of Dallman Р., Gurney J.M., HallЬerg L, Sood S.K. & Srikantia S.G..Preventing and controlling iron deficiency anaemia through primary health care. А guide for health administrators and programme мanagers. World Неаltн Organization. Geneva, 1989.


19. Pizarro F., et al. Iron status with different infant regimens: relevance to screening and prevention of iron deficiency. J Pediatrics. 1991;118:687–92. Doi: 10.1016/s0022-3476(05)80027-7.


20. Breymann C. Iron deficiency Anemia in pregnancy. Semin Hematol. 2015;52:339–47. Doi: 10.1053/j.seminhematol.2015.07.003.


21. Mettananda S., Suranjan M., Fernando R., et al. Anaemia among females in child-bearing age: Relative contributions, effects and interactions of alpha- and beta-thalassaemia. PLoS ONE. 2018;13:e0206928. Doi: 10.1371/journal.pone.0206928.


22. Huynh B.T., Cottrell, G., Cot M., Briand V. Burden of malaria in early pregnancy: A neglected problem? Clin Infect Dis. 2015;60:598–604. Doi: 10.1093/cid/ciu848.


23. Chen C., Grewal J., Betran A.P., et al. Severe anemia, sickle cell disease, and thalassemia as risk factors for hypertensive disorders in pregnancy in developing countries. Pregnancy Hypertens. 2018;13:141–47. Doi: 10.1016/j.preghy.2018.06.001


24. See Ling Loy, Li Min Lim, Shiao-Yng Chan, et al. Iron status and risk factors of iron deficiency among pregnant women in Singapore: a cross-sectional study. BMC Public Health. 2019:19(1):397. Doi: 10.1186/s12889-019-6736-y.


25. Crispin P.J., Sethna F., Andriolo K. Red cell and reticulocyte parameters for the detection of iron deficiency in pregnancy. Clin Lab. 2019;65(11). Doi: 10.7754/Clin.Lab.2019.190427.


26. Sharma J.B., Bumma S.D., Saxena R., et al. Cross sectional, comparative study of serum erythropoietin, transferrin receptor, ferritin levels and other hematological indices in normal pregnancies and iron deficiency anemia during pregnancy. Eur J Obstet Gynecol Reprod Biol. 2016;203:99–103.


27. Tomkins A. Assessing micronutrient status in the presence of inflammation. J Nutr. 2003;133:1649s–55s. Doi: 10.1093/jn/133.5.1649S.


28. Ganz T., Nemeth E. Iron sequestration and anemia of inflammation. Semin Hematol. 2009;46:387–93. Doi: 10.1053/j.seminhematol.2009.06.001.


29. Guida C., Altamura S., Klein F.A., et al. A novel inflammatory pathway mediating rapid hepcidin-independent hypoferremia. Blood. 2015;125:2265–75. Doi: 10.1182/blood-2014-08-595256.


30. Byg K.E., Milman N., Ole Agger A. Correlations between iron status markers during normal pregnancy in women with and without Iron supplementation. Hematology. 2000;4:529–39.


31. Yokoi K. Estimation of iron requirements for women by numerical analysis of population-based data from the National Health and Nutrition Surveys of Japan 2003–2007. J Trace Elem Med Biol. 2014;28:453–58. Doi: 10.1016/j.jtemb.2014.07.011.


32. North M., Dallalio G., Donath A.S., et al. Serum transferrin receptor levels in patients undergoing evaluation of iron stores:correlation with other parameters, and observed versus predicted results. Clin Lab Haematol. 1997;19:93–7.


33. Milman N., Pedersen N.S., Visfeldt J. Serum ferritin in healthy Danes: Relation to marrow haemosiderin iron stores. Dan Med Bull. 1983;30:115–20.


34. Means R.T., Allen J., Sears D.A., Schuster S.J. Serum soluble transferrin receptor and the prediction of marrow aspirate results in a heterogeneous group of patients. Clin Lab Haematol. 1999;21:161–67. Doi: 10.1046/j.1365-2257.1999.00224.x.


35. Allen J., Backstrom K.R., Cooper J.A., et al. Measurement of soluble transferrin receptor in serum of healthy adults. Clin Chem. 1998;44:35–9.


36. Akinsooto V., Ojwang P.J., Govender T., et al. A. Soluble transferrin receptors in anaemia of pregnancy. J Obstet Gynaecol. 2001;21:250–52. Doi: 10.1080/01443610120046341.


37. Beguin Y. Soluble transferrin receptor for the evaluation of erythropoiesis and iron status. Clin Chim Acta. 2003;329:9–22. Doi: 10.1016/s0009-8981(03)00005-6.


38. Milman N. Prepartum anaemia: Prevention and treatment. Ann Hematol. 2008;87:949–59. Doi: 10.1007/s00277-008-0518-4.


39. Диагностика и лечение железодефицитной анемии у детей и подростков. Под ред. А.Г. Румянцева, И.Н. Захаровой, М., 2015. 76 с.


40. Auerbach M., Abernathy J., Juul S., et al. Prevalence of iron deficiency in first trimester, nonanemic pregnant women. J Mater Fetal Neonatal Med. 2019 Jun 3;1–4. Doi: 10.1080/14767058.2019.1619690.


41. Milman N., Graudal N., Nielsen O.J., Agger A.O. Serum erythropoietin during normal pregnancy: Relationship to hemoglobin and iron status markers and impact of iron supplementation in a longitudinal, placebo-controlled study on 118 women. Int J Hematol. 1997;66:159–68.


42. Horowitz K.M., Ingardia C.J., Borgida A.F. Anemia in pregnancy. Clin Lab Med. 2013;33:281–91. Doi: 10.1016/j.cll.2013.03.016.


43. de Haas S., Ghossein-Doha C., van Kuijk S.M., et al. Physiological adaptation of maternal plasma volume during pregnancy: A systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2017;49:177–87. Doi: 10.1002/uog.17360.


44. Stangret A., Skoda M., Wnuk A., et al. Mild anemia during pregnancy upregulates placental vascularity development. Med Hypotheses 2017;102:37–40.Doi: 10.1016/j.mehy.2017.03.007.


45. Zimmermann M.B., Burgi H., Hurrell R.F. Iron deficiency predicts poor maternal thyroid status during pregnancy. J Clin Endocrinol Metab. 2007;92(9):3436–40. Doi: 10.1210/jc.2007-1082.


46. Drukker L., Hants Y., Farkash R., et al. Iron deficiency anemia at admission for labor and delivery is associated with an increased risk for Cesarean section and adverse maternal and neonatal outcomes. Transfusion. 2015;55(12):2799–806. Doi: 10.1111/trf.13252.


47. Juula S.E., Derman R.J., Auerbach M. Perinatal Iron Deficiency: Implications for Mothers and Infants. Neonatology. 2019;115:269–74. Doi: 10.1159/000495978.


48. Huang A., Zhang R., Yang Z. Quantitative (stereological) study of placental structures in women with pregnancy iron-deficiency anemia. Eur J Obstet Gynecol Reprod Biol. 2001;97:59–64. doi: 10.1016/s0301-2115(00)00480-2.


49. Tran P.V., Fretham S.J., Carlson E.S., Georgieff M.K. Long-term reduction of hippocampal brain-derived neurotrophic factor activity after fetal-neonatal iron deficiency in adult rats. Pediatr Res. 2009;65(5):493–98. Doi: 10.1203/PDR.0b013e31819d90a1.


50. Congdon E.L., Westerlund A., Algarin C.R., et al. Iron deficiency in infancy is associated with altered neural correlates of recognition memory at 10 years. J Pediatr. 2012;160(6):1027–33. Doi: 10.1016/j.jpeds.2011.12.011.


51. Lozoff B. Iron deficiency and child development. Food Nutr Bull. 2007;28(4 Suppl):S560–71. Doi: 10.1177/15648265070284S409.


52. Lozoff B., Jimenez E., Smith J.B. Double burden of iron deficiency in infancy and low socio-economic status: a longitudinal analysis of cognitive test scores to age 19 years. Arch Pe-diatr Adolesc Med. 2006;160(11):1108–13. Doi: 10.1001/archpedi.160.11.1108.


53. Ellman L.M., Vinogradov S., Kremen W.S., et al. Low maternal hemoglobin during pregnancy and diminished neuromotor and neurocognitive performance in offspring with schizophrenia. Schizophr Res. 2012;138:81–7. Doi: 10.1016/j.schres.2012.04.008.


54. Scholl T.O. Maternal iron status: relation to fetal growth, length of gestation, and iron endowment of the neonate. Nutr Rev. 2011;(69 Suppl 1):S23–29. Doi: 10.1111/j.1753-4887.2011.00429.x.


55. Milman N., Bergholt T., Byg K.E., et al. Iron status and iron balance during pregnancy. A critical reappraisal of iron supplementation. Acta Obstet Gynecol Scand. 1999;78:749–57.


56. Milman N., Graudal N., Agger A.O. Iron status markers during pregnancy. No relationship between levels at the beginning of the second trimester, prior to delivery and post partum. J Intern Med. 1995;237:261–67. Doi: 10.1111/j.1365-2796.1995.tb01174.x.


57. Предгравидарная подготовка: клинический протокол (авт.-разраб. В.Е. Радзинский и др.). М., 2016. 80 с.


58. Means R.T. Iron Deficiency and Iron Deficiency Anemia: Implications and Impact in Pregnancy, Fetal Development, and Early Childhood Parameters. Nutrients. 2020;12:447. Doi: 10.3390/nu12020447.


59. 59Milman N. Iron prophylaxis in pregnancy–General or individual and in which dose? Ann Hematol. 2006;85:821–28. Doi: 10.1007/s00277-006-0145-x.


60. Pena-Rosas J.P., De-Regil L.M., Gomez Malave H.,et al. Intermittent oral iron supplementation during pregnancy. Cochrane Database Syst Rev. 2015;(10):CD009997. Doi: 10.1002/14651858.CD009997.pub2.


61. Moretti D., Goede J.S., Zeder C., et al. Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily dos-es in iron-depleted young women. Blood. 2015;126(17):1981–89. Doi: 10.1182/blood-2015-05-642223.


62. Beard J.L. Iron requirements in adolescent females. J Nutr. 2000;130(2S, Suppl.):440S-442S. Doi: 10.1093/jn/130.2.440S.


63. Levy A., Fraser D., Katz M., et al. Maternal anemia during pregnancy is an independent risk factor for low birthweight and preterm delivery. Eur J Obstet Gynecol Reprod. Biol. 2005;122:182–86. Doi: 10.1016/j.ejogrb.2005.02.015.


64. Parisi F., Berti C., Mandò C., et al. Effects of different regimens of iron prophylaxis on maternal iron status and pregnancy outcome: a randomized control trial. J Matern Fetal Neonatal Med. 2017;30(15):1787–92. Doi: 10.1080/14767058.2016.1224841.


65. Rioux F.M., Belanger-Plourde J., Leblanc C.P., Vigneau F. Relationship between maternal DHA and iron status and infants’ cognitive performance. Can J Diet Pract Res. 2011;72:76. Doi: 10.3148/72.2.2011.e140.


66. Larson L.M., Phiri K.S., Pasricha S.R. Iron and cognitive development: What Is the evidence? Ann Nutr Metab. 2017;71(Suppl. 3):25–38. Doi: 10.1159/000480742.


67. Yakoob M.Y., Bhutta Z.A. Effect of routine iron supplementation with or without folic acid on anemia during pregnancy. BMC Public Health 2011;11(Suppl. 3):S21. Doi: 10.1186/1471-2458-11-S3-S21.


68. Mahomed K. Iron supplementation in pregnancy. Cochrane Database Syst Rev. 2000;(2):CD000117. Doi: 10.1002/14651858.CD000117.


69. Siu A.L. Screening for iron deficiency anemia and iron supplementation in pregnant women to improve maternal health and birth outcomes: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2015;163:529–36. Doi: 10.7326/M15-1707.


70. Коноводова Е.Н., Серов В.Н., Бурлев В.А. и др. Клинический протокол: диагностика, профилактика и лечение железодефицитных состояний у беременных и родильниц. Акушерство и гинекология. 2012; 4/2:3–9.


71. Рекомендации ВОЗ по оказанию дородовой помощи как средству формирования позитивного опыта беременности. 2017. 175 с.


72. Guideline: Daily iron supplementation in adult women and adolescent girls. Geneva: World Health Organization; 2016.


73. Guideline: Intermittent iron and folic acid supplementation in menstruating women. Geneva: World Health Organization; 2016.


74. Stuklov N.I., Alpidovsky V.K., Ogurtsov P.P. Anemia Clinic, diagnosis and treatment. A manual for doctors, M., 2013. 264 p.


75. Fleming R.E. Iron and inflammation: cross talk between pathways regulating hepcidin. J Mol Med. 2008;86(5):491–94. Doi: 10.1007/s00109-008-0349-8.


76. Achebe M.M., Gafter-Gvili A. How I treat anemia in pregnancy: iron, cobalamin, and folate. Blood. 2017;129(8):940–49. Doi: 10.1182/blood-2016-08-672246.


77. Jahn M.R., Andreasen H.B., Fütterer S., et al. A compara-tive study of the physicochemical properties of iron isomaltoside 1000 (Monofer), a new intravenous iron preparation and its clinical implications. Eur J Pharm Biopharm. 2011;78(3):480–91. Doi: 10.1016/j.ejpb.2011.03.016.


78. Myers B., Myers O., Moore J. Comparative efficacy and safety of intravenous ferric car-boxymaltose (Ferinject) and iron(III) hy-droxide dextran (Cosmofer) in pregnancy. Obstet Med. 2012;5(3):105–7. Doi: 10.1258/om.2012.110095.


79. Wong L., Smith S, Gilstrop M., et al. Safety and efficacy of rapid (1,000 mg in 1 hr) intravenous iron dextran for treatment of maternal iron defi-cient anemia of pregnancy. Am J Hematol. 2016;91(6):590–93. Doi: 10.1002/ajh.24361.


80. Auerbach M., James S.E., Nicoletti M., et al. Results of the First American Prospective Study of Intravenous Iron in Oral Iron-Intolerant Iron-Deficient Gravidas. Am J Med. 2017;130(12):1402–407. Doi: 10.1016/j.amjmed.2017.06.025.


Об авторах / Для корреспонденции


Автор для связи: Н.И. Стуклов, д.м.н., профессор кафедры госпитальной терапии с курсами эндокринологии, гематологии и клинической 
лабораторной диагностики Медицинского института РУДН, рук. курса гематологии; главный научный сотрудник отделения высокодозной химиотерапии с блоком трансплантации костного мозга МНИОИ им. П.А. Герцена, филиал НМИЦ радиологии, Москва, Россия; e-mail: stuklovn@gmail.com
Адрес: 117198, Россия, Москва, ул. Миклухо-Маклая, 6 


ORCID:
Н.И. Стуклов, https://orcid.org/0000-0002-4546-1578 
Т.В. Сушинская, https://orcid.org/0000-0001-8812-9105 
А.А. Митченкова, https://orcid.org/0000-0001-8344-7817 
М.С. Ковальчук, https://orcid.org/0000-0002-3847-504X 


Бионика Медиа